Virax Biolabs Group's inventory is $48K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest inventory for VRAX is $48K as of March 2026. That compares with $95K in the prior-year period — down 49.3% year over year. Investors often review this figure alongside Virax Biolabs Group's historical trend and sector peers before judging valuation or financial health.
Over the past year, VRAX's inventory moved from $95K to $48K — a 49.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Virax Biolabs Group's operating scale or balance-sheet position.
A inventory figure of $48K for VRAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting VRAX's inventory ($48K), review year-over-year change from $95K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.